Earnings
GILD
66.94
-0.06%
-0.04
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2019-12-31
11.63B
12.72B
--
3.58B
--
--
0.00
--
922.00M
--
1.40B
37.00M
30.30B
5.17B
--
1.49B
--
4.12B
13.79B
--
6.77B
31.33B
61.63B
--
713.00M
0.00
--
--
--
--
--
6.25B
--
--
--
293.00M
9.76B
22.09B
--
--
--
7.12B
29.34B
38.98B
1.00M
3.05B
19.39B
--
--
125.00M
22.52B
22.65B
61.63B
FY 2018-12-31
17.94B
12.15B
--
3.33B
--
--
0.00
--
814.00M
--
1.53B
73.00M
35.84B
4.01B
--
1.42B
--
4.12B
15.74B
--
2.56B
27.84B
63.67B
--
790.00M
0.00
--
--
--
--
--
6.88B
--
--
--
191.00M
10.61B
24.57B
--
--
5.92B
6.96B
31.68B
42.14B
1.00M
2.28B
19.02B
--
--
147.00M
21.39B
21.53B
63.67B
FY 2017-12-31
7.59B
17.92B
--
3.85B
--
--
0.00
--
801.00M
--
1.65B
12.00M
31.82B
3.29B
--
11.19B
--
4.16B
17.10B
--
2.71B
38.46B
70.28B
--
814.00M
0.00
--
--
--
--
--
7.27B
--
--
--
803.00M
11.63B
30.80B
--
--
6.79B
7.35B
38.21B
49.78B
1.00M
1.26B
19.01B
--
--
59.00M
20.44B
20.50B
70.28B
FY 2016-12-31
8.23B
3.67B
--
4.51B
--
--
0.00
--
1.59B
--
1.59B
--
19.59B
2.87B
--
20.50B
--
1.17B
8.97B
--
3.89B
37.39B
56.98B
--
1.21B
0.00
--
--
--
--
--
7.78B
--
--
--
237.00M
9.22B
26.35B
--
--
1.75B
2.05B
28.87B
37.61B
1.00M
454.00M
18.15B
--
--
476.00M
18.89B
19.36B
56.98B
FY 2015-12-31
12.85B
1.76B
--
5.85B
--
--
0.00
--
1.96B
--
1.01B
1.33B
24.76B
2.28B
--
11.60B
--
1.17B
10.25B
--
1.66B
26.95B
51.72B
--
1.18B
0.00
--
--
--
--
--
7.26B
--
--
--
473.00M
9.89B
21.07B
--
--
1.24B
1.64B
23.29B
32.60B
1.00M
444.00M
18.00B
--
--
579.00M
18.53B
19.11B
51.72B

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out GILD latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Gilead Sciences recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.